- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Stress Hormone Shields Fetus
10 October 2001 7:00 pm
To survive in utero, the fetus must resist an onslaught by the mother's immune system that, most researchers agree, recognizes the father's share of the embryo as foreign and sometimes rejects it. Now, endocrinologists have determined that the principal soother of the maternal immune system is the same master hormone that commands the body's stress response. The results could help explain some infertility and recurring miscarriages.
Immunologists have long speculated that hormone changes early in pregnancy somehow alter the mother's immune system, but they couldn't pinpoint the mechanism. In the early 1990s, pediatric endocrinologist George Chrousos and his colleagues at the National Institute of Child Health and Human Development in Bethesda, Maryland, came across a clue. They found that corticotropin-releasing hormone (CRH), secreted by the hypothalamus to induce secretion of stress hormones by the pituitary and the adrenal glands, also appeared around sites of inflammation in adults. The correlation was so striking that the researchers decided to see whether CRH played a role in fetal implantation, which initially resembles an inflammation.
Chrousos's group looked for CRH in human trophoblast cells, special cells that help form the placenta, in petri dishes. Not only did the cells churn out CRH, they also harbored cell surface receptors for the hormone. CRH, in turn, triggered production of the cell surface protein FasL; trophoblasts expressing FasL then form a protective shield of sorts around the embryo by forcing any attacking immune cells to self-destruct. This suggested that blocking CRH should reduce the number of implanted fetuses--which, the team reports in the November issue of Nature Immunology, is indeed the case. When the researchers administered antalarmin, a CRH blocker, to pregnant rats during the first 6 days after conception, the number of implanted embryos was reduced by up to 70%. Chrousos thinks a potential cause of unexplained infertility or recurring early miscarriages in women might be due to a lack of CRH to prevent immune rejection.
While some scientists continue to question whether the fetus does kick off a maternal immune response, others are fascinated by Chrousos's findings. "Nobody has ever shown how FasL is induced" in the developing placenta, says reproductive immunologist Scott Kauma of the Virginia Commonwealth University in Richmond. "This adds to the importance of neuroendocrine hormones as key factors in regulating the maternal immune response" during pregnancy.